Search results
Peninsula cancer test maker lands key nod from FDA panel, a step toward a big payday - San Francisco...
The Business Journals· 1 day agoShares of Guardant Health Inc. closed Friday more than 13% higher day-over-day, after the Palo Alto...
Many people quit new weight-loss drugs because of costs, side effects
UPI· 2 days agoReasons for quitting Wegovy, Ozempic or similar drugs may include cost or gastrointestinal side...
Plant-based diet may boost health for women with breast cancer
Futurity· 4 days agoIn a new clinical trial, women with breast cancer who exclusively ate a whole-foods, plant-based...
Cleveland Clinic is Florida’s destination for cancer care
Miami Herald via AOL· 7 days agoMany drugs...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF...
WKRN Nashville· 6 days agoFood and Drug Administration (FDA) has granted Orphan Drug Designation to Cantex' azeliragon, a well-tolerated once-a-day pill, for the treatment of pancreatic ...
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
Digital Journal· 2 days ago83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression ...
US pediatricians group reverses decades-old ban on breastfeeding for those with HIV
Eyewitness News 3 Hartford· 6 days agoThe new report from the American Academy of Pediatrics reverses recommendations it had in place...
Drug Discovery, Development and Evaluation Hub Welcomes New Faculty to Fuel Innovation
UB Reporter· 5 days agoThe University at Buffalo School of Pharmacy and Pharmaceutical Sciences’ (UB SPPS) Drug Discovery, Development and Evaluation (DDDE) Hub, a leading research engine in the ...
U.S. pediatricians reverse decades-old advice against HIV-positive mothers breastfeeding | Texarkana...
Texarkana Gazette· 4 hours agoThe new report from the American Academy of Pediatrics reverses recommendations it had in place...
Exemestane Plus Ovarian Suppression Best in Early ILC
Medscape· 2 days agoNew data add to the body of evidence favoring the aromatase inhibitor therapy plus ovarian suppression over tamoxifen for premenopausal women with early invasive lobular carcinoma.